Collaboration Requet from Adaptive Biotechnologies

18 Mar 2021 9:24 AM | Sheilah Jewart (Administrator)

Adaptive Biotechnologies, an immune profiling company based in Seattle, has been working through partnerships with research groups worldwide to better understand T cell responses to Lyme and other Tick-Borne illnesses and how these immune signatures might inform the development of a T cell-based diagnostic. As an example of how we have done this in other diseases please see our recent work in COVID-19 published by Snyder et al 2020Our focus right now is identifying investigators who have banked patient samples or the ability to collect samples during the coming season. Since our assay studies the cellular response in diseases like Lyme we would run T-cell Receptor (TCR) sequencing on whole blood (2 mLs), buffy coat (~3 million cells), or DNA (18 ug) from either. 

Heidi Chapman, PhD
Partnership Management Specialist
603-630-5502 - Seattle, WA
hchapman@adaptivebiotech.com

Author
Comment
 

Comments

American Society for Rickettsiology

ASR is a 501(c)3 non-profit organization. Michigan , 9037 Ron Den Lane, Windermere, FL 34786

Powered by Wild Apricot Membership Software